Finance

Lists
Q3 2026 earnings • released • Revenue beat +၃၅.၃၉%
See results
SDGR:NASDAQ
Schrodinger Inc
၂၈.၇၇ US$
+၀.၈၈%
(+၀.၂၅) 1D
၂၇.၉၁ US$
-၂.၉၉% (-၀.၈၆)
After hours
Closed: နို ၅, GMT-၅ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SDGR...
Open
၂၉.၁၀ US$
High
၃၀.၀၉ US$
Low
၂၇.၁၆ US$
Mkt. cap
၂၁၅.၂၂ ဋေ
Avg. vol.
၂.၃၂ သန်း
Volume
၂.၂၂ သန်း
52-wk high
၃၃.၇၈ US$
52-wk low
၁၀.၉၅ US$
EPS
-၀.၇၄ US$
Beta
၁.၆၉
Shares outstanding
၆.၅၆ ကုဋေ
No. of employees
၈၅၀
Open
၂၉.၁၀ US$
High
၃၀.၀၉ US$
Low
၂၇.၁၆ US$
Mkt. cap
၂၁၅.၂၂ ဋေ
Avg. vol.
၂.၃၂ သန်း
Volume
၂.၂၂ သန်း
52-wk high
၃၃.၇၈ US$
52-wk low
၁၀.၉၅ US$
EPS
-၀.၇၄ US$
Beta
၁.၆၉
Shares outstanding
၆.၅၆ ကုဋေ
No. of employees
၈၅၀
News stories
From web sources and news partners
GuruFocus
GuruFocus
·
ပြီးခဲ့သည့် ၁၅ နာရီ
Schrödinger (SDGR) Reports Strong Q3 Growth, Raises 2026 ACV Gui
Yahoo Finance Singapore
Yahoo Finance Singapore
·
ပြီးခဲ့သည့် ၂၃ နာရီ
Schrodinger Inc (SDGR) (Q3 2026) Earnings Call Highlights: Raised Guidance and Strong ACV ...
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ ရက်
What Schrodinger (SDGR) Said on Its Q3 Earnings Call
Zacks
Zacks
·
ပြီးခဲ့သည့် ၁ ရက်
Schrodinger, Inc. (SDGR) Reports Q3 Loss, Beats Revenue Estimates
Profile
Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science. Schrödinger's software is used by pharmaceutical companies, biotech, tech, chemicals, energy, aerospace firms, and academic researchers to simulate and model the behavior of molecules at the atomic level. This accelerates the design and develops new drugs and materials more efficiently, reducing the time and cost of bringing them to market. Schrödinger's software tools include molecular dynamics simulations, free energy calculations, quantum mechanics calculations, and virtual screening tools. The company also offers consulting services and collaborates with partners in the industry to advance the field of computational chemistry and drug discovery. Wikipedia
About Schrodinger Inc
CEORamy Farid
Employees၈၅၀
Founded၁၉၉၀
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 6 analysts giving stock ratings to SDGR in the past 3 months
Buy
Buy
4
Hold
2
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for SDGR in the last 3 months.
Highest
Current ၂၈.၇၇ US$
၃၆.၀၀ US$ (+၂၅.၁၃%)
Average
၃၀.၆၀ US$ (+၆.၃၆%)
Lowest
၂၁.၀၀ US$ (-၂၇.၀၁%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brendan Smith
TD Cowen
Buy
Maintained
၃၆.၀၀ US$
+၂၅.၁%
11/05/2026
Sean Laaman
Morgan Stanley
Hold
Reiterated
၂၉.၀၀ US$
+၀.၈%
11/05/2026
Craig Hettenbach
Morgan Stanley
Hold
Reiterated
၂၉.၀၀ US$
+၀.၈%
11/05/2026
Evan Seigerman
BMO Capital
Buy
Reiterated
၃၅.၀၀ US$
+၂၁.၇%
11/05/2026
Kevin Caliendo
UBS
Hold
Reiterated
၂၁.၀၀ US$
-၂၇%
10/20/2026
Scott Schoenhaus
KeyBanc
Buy
Maintained
၃၂.၀၀ US$
+၁၁.၂%
10/16/2026
Michael Ryskin
Bank of America Securities
Buy
Maintained
-
-
08/06/2026
Matt Hewitt
Craig-Hallum
Buy
Maintained
-
-
07/08/2026
Michael Yee
UBS
Hold
Reiterated
၁၃.၀၀ US$
-၅၄.၈%
03/17/2026
Last report
၂၀၂၆ နို ၄
Fiscal period
Q3 2026
- / -၀.၅၂ US$
Revenue / Est. (USD)
၆.၄၅ ကုဋေ / ၄.၇၆ ကုဋေ
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
၂၀၂၆ စက်
Revenue
၈.၇၂ ကုဋေ
၅.၈၆ ကုဋေ
၅.၈၉ ကုဋေ
၆.၄၅ ကုဋေ
Cost of goods sold
၂.၉၉ ကုဋေ
၂.၉၀ ကုဋေ
၂.၆၅ ကုဋေ
-
Cost of revenue
၂.၉၉ ကုဋေ
၂.၉၀ ကုဋေ
၂.၆၅ ကုဋေ
၂.၆၂ ကုဋေ
Research and development expenses
၄.၁၄ ကုဋေ
၄.၃၈ ကုဋေ
၄.၁၀ ကုဋေ
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃.၃၁ ကုဋေ
၃.၄၅ ကုဋေ
၃.၃၀ ကုဋေ
-
Operating expense
၇.၄၄ ကုဋေ
၇.၈၃ ကုဋေ
၇.၄၀ ကုဋေ
-
Total operating expenses
၁၀.၄၄ ကုဋေ
၁၀.၇၄ ကုဋေ
၁၀.၀၄ ကုဋေ
-
Operating income
-၁.၇၂ ကုဋေ
-၄.၈၈ ကုဋေ
-၄.၁၅ ကုဋေ
-၂.၆၁ ကုဋေ
Other non operating income
၃.၁၃ သန်း
၂.၆၆ သန်း
၃.၀၃ သန်း
-
EBT including unusual items
၃.၃၀ ကုဋေ
-၅.၉၆ ကုဋေ
၇.၃၅ သန်း
-၃.၇၆ ကုဋေ
EBT excluding unusual items
-၁.၄၀ ကုဋေ
-၄.၆၁ ကုဋေ
-၃.၈၅ ကုဋေ
-
Income tax expense
၄.၆၂ သိန်း
၄.၀၈ သိန်း
၁.၃၇ သန်း
-
Effective tax rate
၁.၄၀%
-၀.၆၈%
၁၈.၆၇%
-
Other operating expenses
-
-
-
-
Net income
၃.၂၅ ကုဋေ
-၆.၀၀ ကုဋေ
၅.၉၈ သန်း
-
Net profit margin
၃၇.၂၇%
-၁၀၂.၄၆%
၁၀.၁၅%
-
Earnings per share
-၀.၁၈
-၀.၆၂
-၀.၄၂
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၅၇ ကုဋေ
-၄.၇၃ ကုဋေ
-၄.၀၁ ကုဋေ
-၂.၄၇ ကုဋေ
Gain or loss from assets sale
-
၁.၁၀ သောင်း
-၁.၂၀ သောင်း
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ